NK-Cell Lymphoma, Unclassifiable
NCI Definition: A very rare NK-cell lymphoma with pathologic and clinical features posing difficulty in its exact diagnosis and classification. 
There is 1 clinical trial for NK-cell lymphoma, unclassifiable, of which 0 are open and 1 is completed or closed. Of the trial that contains NK-cell lymphoma, unclassifiable as an inclusion criterion, 1 is phase 2 (0 open).
Nivolumab is the most common intervention in NK-cell lymphoma, unclassifiable clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.